Compliance Group to showcase AI compliance tools at ISPE annual meeting

Compliance Group Inc. will present AI-enabled quality, compliance and validation tools at the 2026 ISPE Annual Meeting & Expo in Washington, D.C., including a featured session on autonomous quality systems. The company will also demo its AI agents at Booth 907 and highlight how the tools are designed to support risk-based decisions while maintaining regulatory rigor.

Why it matters: - Compliance Group is aiming to show how AI can speed validation and quality work in regulated life sciences without weakening compliance controls. - The company’s pitch centers on risk-based decision-making, auditability and human oversight, all priorities for pharmaceutical and biopharmaceutical teams.

What happened: - Compliance Group Inc. will participate in the 2026 ISPE Annual Meeting & Expo from October 18-21, 2026, in Washington, D.C., with virtual access available. - Khaled Moussally, EVP managing partner at Compliance Group, will join Daniel Walter, policy analyst at the FDA, and Louie Rayal, VP of governance, risk & compliance at GSK, for a featured session on October 20, 2026, from 11:30 AM to 12:00 PM. - The session is titled "Autonomous Quality Systems – AI-Enabled Compliance." - Compliance Group will also exhibit at Booth 907.

The details: - The featured session will cover AI use across the validation lifecycle within a Computer Software Assurance framework. - The discussion will address risk assessment, FMEA, test script generation, execution traceability and summary reporting. - The session content is aligned with FDA CSA guidance, ICH Q9(R1) and GAMP 5 Second Edition. - Attendees will hear how AI can support risk-based testing, identify critical functionality and generate audit-ready rationale. - The session will also focus on data integrity, human oversight and auditability of AI-assisted decisions. - At Booth 907, Compliance Group will demo iQuality and AI agents for Audit Trail Review (ATR), Annual Product Quality Review (APQR) and Digital Validation Documentation (VERA). - Those tools run on CLAiRE, the company’s Agentic AI Platform. - Compliance Group says the demos will show how the tools streamline quality workflows, strengthen compliance and support efficient, risk-based approaches to quality and validation. - The company will have team members available at the booth, including Khaled Moussally, Jonathan Meuzelaar, Venkata Phani Kiran Nandula, Sarada Ramamoorthy, Hillary Driscoll, Elizabeth Prager, Emily Carolan and Theresa Noonan. - Compliance Group says its broader business spans quality, validation, regulatory compliance, digital transformation, specialized resourcing, managed services and AI-enabled solutions for life sciences organizations. - The company says its mission is to "Accelerate Innovation in Life Sciences." - For more information about CG’s AI capabilities, visit the company’s website. - The company also shared social links for LinkedIn, Instagram, Facebook and YouTube.

Between the lines: - The FDA and GSK participation gives the session added credibility with a compliance-focused audience. - Compliance Group is positioning AI as a practical layer for regulated workflows, not as a replacement for expert review. - The emphasis on audit readiness and traceability signals that the company is targeting buyers who need efficiency gains without added regulatory risk.

What's next: - Compliance Group will present its session and booth demos during the October 18-21 conference window. - The company is likely using the event to generate interest in its AI-enabled quality and validation offerings ahead of broader adoption across life sciences teams. - Attendees can meet the team at Booth 907 and explore the AI tools in person.